Imodium Instant Melts

Loperamide Hydrochloride, the active ingredient in Imodium Instant Melts, is an antidiarrheal presented as an oral dissolving film for oral use. It treats acute nonspecific diarrhea, chronic diarrhea associated with inflammatory bowel disease, and travelers' diarrhea in adults and children as directed.

GNH USA supplies Imodium Instant Melts as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imodium Instant Melts (loperamide) is used to manage conditions involving increased intestinal motility. - Acute nonspecific diarrhea: reduces stool frequency and improves consistency. - Chronic diarrhea associated with inflammatory bowel disease: helps control symptoms by slowing transit. - Travelers' diarrhea: provides symptomatic relief during short‑term travel‑related episodes.

Loperamide may cause a range of adverse reactions, most of which are mild and dose‑related.

Common Side Effects: - Constipation: reduced bowel movements. - Abdominal cramps: mild stomach discomfort. - Nausea: feeling of sickness. - Dizziness: light‑headed sensation. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Severe constipation leading to bowel obstruction. - Toxic megacolon: rare but life‑threatening colonic dilation. - Cardiac arrhythmias: especially with high doses or drug interactions. - Allergic reactions: rash, itching, swelling. - Central nervous system depression: extreme drowsiness or coma (very rare).

Before using Imodium Instant Melts, consider the following precautions to ensure safe and effective use. - Assess underlying cause: avoid use if diarrhea is due to bacterial infection requiring antibiotics. - Pediatric use: limit to children over 2 years and follow prescriber guidance. - Renal impairment: adjust use in patients with severe kidney dysfunction. - Hepatic impairment: use cautiously in liver disease. - Concomitant opioid use: increased risk of central effects; monitor closely. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Loperamide can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase loperamide plasma levels and risk of cardiac toxicity. - P-glycoprotein inhibitors (e.g., quinidine, verapamil): raise systemic exposure, heightening adverse effects. - Other opioid agonists: additive central opioid effects, potentially causing respiratory depression.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may enhance constipation. - Antidiarrheal agents (e.g., diphenoxylate): risk of excessive slowing of gut motility. - Certain antidepressants (e.g., sertraline): monitor for QT prolongation when combined with CYP3A4 inhibitors.